This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Bernstein Liebhard LLP
Bernstein Liebhard LLP continues to investigate meningitis lawsuits on behalf of alleged victims of NECC epidural steroid injections.
New York, NY (PRWEB) November 17, 2012
With meningitis lawsuits moving forward, the U.S Centers for Disease Control (CDC) says 480 cases of meningitis and other fungal infections have been reported in people who received epidural steroid injections supplied by the New England Compounding Center (NECC), Bernstein Liebhard reports. The case count includes 469 cases of fungal meningitis, 33 of which were fatal, in people who received the steroids to treat back pain. Eleven peripheral joint infections were reported in patients who received steroid injections in their hips, knees, shoulders and other joints.*
According to a report from The New York Times, the Commissioner of the U.S. Food & Drug Administration (FDA) has called on Congress to provide the agency with more authority to police compounding pharmacies like NECC. During testimony before the House Committee on Energy and Commerce on Wednesday, Dr. Margaret Hamburg asserted that conflicting court decisions and a lack of clarity in the law had limited the agency’s ability to act against compounding pharmacies that fail to meet basic safety standards. Compounding pharmacies are now regulated primarily by the states, the Times said.**
“This meningitis outbreak has made it more than apparent that compounding pharmacies like NECC are not being subjected to adequate oversight. We hope Congress will take Dr. Hamburg’s testimony seriously, and work in a bipartisan manner to protect the public from future catastrophes like this,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free legal evaluations to alleged victims of NECC’s epidural steroid injections.
Fungal Meningitis Lawsuits
In October, plaintiffs in fungal meningitis lawsuits petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) for consolidation of all federally-filed claims in Minnesota federal court. In a brief submitted to the JMPL on November 7th, NECC indicated it had been named in 28 meningitis lawsuits in various federal courts. NECC said it supports the establishment of a multidistrict litigation, but asked the Panel to consider Massachusetts federal court as the venue for the consolidated proceedings. [In Re: New England Compounding Pharmacy, Inc. Products Liability Litigation, MDL No. 2419 (JPML).]
Victims of the fungal meningitis outbreak linked to NECC’s epidural steroid injections may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing a fungal meningitis lawsuit by visiting Bernstein Liebhard LLP’s website http://www.consumerinjurylawyers.com/. For additional information, contact one of the firm’s fungal meningitis lawyers today at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebmeningitis-lawsuits/fungal-meningitis-lawsuit/prweb10144570.htm